Comparison of a global submission of new biological or chemical entity

Mehr zum Buch

The dissertation focuses on creating a comprehensive global regulatory strategy for marketing authorization applications of new chemical and biological entities. It involves a thorough analysis of pharmaceutical legislation and regulatory requirements across over 190 countries, highlighting both commonalities and differences. The objective is to equip stakeholders with the necessary knowledge to navigate diverse regulations effectively, ensuring successful submissions for marketing authorization in various regions worldwide.